GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
May 21, 2024
Host Chris Miglino interviews CFO Jim Heindlmeyer.
May 21, 2024
April 1, 2024
September 13, 2022
December 14, 2022
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.